Indian regulator to be assisted by 12 new drug advisory committees
This article was originally published in SRA
Executive Summary
The Indian Ministry of Health and Family Welfare has formed 12 new drug advisory committees to assist the Drug Controller General of India (DCGI) in reviewing and granting regulatory approval to applications for clinical trials and new drugs (except for investigational new drugs)1.